Llwytho...

Nivolumab-Associated Acute Demyelinating Encephalitis: A Case Report and Literature Review

Nivolumab is a checkpoint inhibiting immunotherapeutic agent prescribed for the treatment of resistant cancers. Many immune-related adverse effects including neurological effects have been described, but central nervous system (CNS) toxicities are rarely reported. We present a 59-year-old Caucasian...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Clin Med Res
Prif Awduron: Zafar, Zubair, Vogler, Carrie, Hudali, Tamer, Bhattarai, Mukul
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Marshfield Clinic 2019
Pynciau:
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC6546281/
https://ncbi.nlm.nih.gov/pubmed/31160476
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3121/cmr.2019.1417
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!